Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The U.S. Food and Drug Administration has approved Roche's cobas HPV Test as the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.

Approval of First HPV Test for Use With SurePath Preservative Fluid

0
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
The once-daily acne treatment Differin Gel 0.1% (adapalene) has been approved for over-the-counter use among patients 12 and older

FDA Approves Differin Gel for Over-the-Counter Use

0
First OTC retinoid available for acne treatment among patients 12 and older
The ExAblate Neuro device has been approved by the U.S. Food and Drug Administration to deliver focused ultrasound to destroy tissue in a tiny area of the brain that is thought to be involved in essential tremor.

FDA Approves Ultrasound Device to Treat Essential Tremor

0
Focused ultrasound device to treat essential tremor in patients who have not responded to medication
The first coronary stent to be gradually absorbed by the body has been approved by the U.S. Food and Drug Administration.

FDA Approves First Absorbable Coronary Stent

0
Device is absorbed by the body after about three years
The Xpert Carba-R Assay diagnostic

FDA Approves New Test to Help Detect Drug-Resistant Bacteria

0
Uses specimens taken directly from patients; specifically looks for resistance to carbapenems
An implant that helps the aging eye focus on small print and nearby objects has been approved by the U.S. Food and Drug Administration.

FDA Approves Eye Implant to Correct Presbyopia in Middle Age

0
Tiny lens reshapes cornea to improve focus on small print, close objects
The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.

FDA Approves Epclusa for Chronic Hepatitis C

0
Combination drug treats six major strains of hepatitis C virus infection
Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response to UDCA

FDA Approves Ocaliva for Primary Biliary Cholangitis

0
For patients who have not responded to, or cannot tolerate, ursodeoxycholic acid
The U.S. Food and Drug Administration has approved the first-ever buprenorphine implant to treat opioid dependence

FDA Approves Probuphine Implant for Opioid Dependence

0
New form of treatment designed to last six months
The U.S. Food and Drug Administration has approved the first-ever buprenorphine implant to treat opioid dependence

FDA Approves Probuphine Implant for Opioid Dependence

0
New form of treatment designed to last six months